Medical Properties Trust (MPW) Stock Price, News & Analysis

Company Overview

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023. Since the end of the third quarter, the Company has sold four facilities and now owns approximately 43,000 licensed beds in nine countries across three continents. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Key Stats

• Today's Range: $4.30 to $4.44
• 50-Day Range: $3.99 to $4.50
• 52-Week Range: $3.51 to $6.55
• Volume: 6.99 million shs
• Average Volume: 8.83 million shs
• Market Capitalization: $2.66 billion
• P/E Ratio: N/A
• Dividend Yield: 7.23%
• Price Target: $5.58
• Consensus Rating: Hold

Medical Properties Trust Stock Analysis - MarketRank™

Medical Properties Trust scored higher than 82% of companies evaluated by MarketBeat, and ranked 272nd out of 934 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.1 / 5
• Analyst Rating: Hold

Consensus Rating

Medical Properties Trust has received a consensus rating of Hold. The company's average rating score is 2.13, and is based on 2 buy ratings, 5 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Medical Properties Trust has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: -20.51%

Earnings Growth

Earnings for Medical Properties Trust are expected to decrease by -20.51% in the coming year, from $0.78 to $0.62 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Medical Properties Trust is -1.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Medical Properties Trust is -1.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Medical Properties Trust has a P/B Ratio of 0.55. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

35.07% of the float of Medical Properties Trust has been sold short.

Short Interest Ratio / Days to Cover

Medical Properties Trust has a short interest ratio ("days to cover") of 19.7, which indicates bearish sentiment.

Change versus previous month

Short interest in Medical Properties Trust has recently decreased by 0.02%, indicating that investor sentiment is improving.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

Medical Properties Trust is a leading dividend payer. It pays a dividend yield of 7.41%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Medical Properties Trust does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Medical Properties Trust will have a dividend payout ratio of 51.61% next year. This indicates that Medical Properties Trust will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.6 / 5
• Environmental Score: -1.40

Percentage of Shares Shorted

35.07% of the float of Medical Properties Trust has been sold short.

Short Interest Ratio / Days to Cover

Medical Properties Trust has a short interest ratio ("days to cover") of 19.7, which indicates bearish sentiment.

Change versus previous month

Short interest in Medical Properties Trust has recently decreased by 0.02%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 1.25

News Sentiment

Medical Properties Trust has a news sentiment score of 1.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Finance companies.

News Coverage This Week

MarketBeat has tracked 15 news articles for Medical Properties Trust this week, compared to 8 articles on an average week.

Search Interest

Only 32 people have searched for MPW on MarketBeat in the last 30 days. This is a decrease of -18% compared to the previous 30 days.

MarketBeat Follows

10 people have added Medical Properties Trust to their MarketBeat watchlist in the last 30 days. This is an increase of 43% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Medical Properties Trust insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.26% of the stock of Medical Properties Trust is held by insiders.

Percentage Held by Institutions

71.79% of the stock of Medical Properties Trust is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

MPW Stock Analysis - Frequently Asked Questions

How have MPW shares performed this year?

Medical Properties Trust's stock was trading at $3.95 at the beginning of the year. Since then, MPW shares have increased by 12.0% and is now trading at $4.4250.

How were Medical Properties Trust's earnings last quarter?

Medical Properties Trust, Inc. (NYSE:MPW) released its quarterly earnings data on Thursday, July, 31st. The real estate investment trust reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.15 by $0.01. The business's revenue for the quarter was down 9.8% on a year-over-year basis.
Read the conference call transcript.

Who are Medical Properties Trust's major shareholders?

Medical Properties Trust's top institutional shareholders include State Street Corp (5.07%), Geode Capital Management LLC (1.75%), Allianz Asset Management GmbH (1.13%) and Bank of New York Mellon Corp (1.04%). Insiders that own company stock include James Kevin Hanna, Rosa Handley Hooper, Michael G Stewart, Elizabeth N Pitman and C Reynolds Thompson III.
View institutional ownership trends.

How do I buy shares of Medical Properties Trust?

Shares of MPW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Medical Properties Trust own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Medical Properties Trust investors own include JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Symbotic (SYM), Voya Infrastructure, Industrials and Materials Fund (IDE), Enterprise Products Partners (EPD), Pfizer (PFE), Energy Transfer (ET) and Verizon Communications (VZ).

Company Calendar

• Record date for 7/17 Dividend: 6/18/2025
• Ex-Dividend for 7/17 Dividend: 6/18/2025
• Dividend Payable: 7/17/2025
• Last Earnings: 7/31/2025
• Today: 8/28/2025
• Record date for 10/9 Dividend: 9/11/2025
• Ex-Dividend for 10/9 Dividend: 9/11/2025
• Dividend Payable: 10/09/2025
• Next Earnings (Estimated): 11/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: REIT - EQTY TRUST - OTHER
• Sub-Industry: Specialized REITs
• Current Symbol: NYSE:MPW
• CIK: 1287865
• Web: www.medicalpropertiestrust.com
• Phone: (205) 969-3755
• Fax: 205-969-3756
• Employees: 120
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Medical Properties Trust: $5.58
• High Price Target: $9.00
• Low Price Target: $4.00
• Potential Upside/Downside: +26.2%
• Consensus Rating: Hold
• Rating Score (0-4): 2.13
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.39)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 5.67
• P/E Growth: N/A
• Net Income: -$2.41 billion
• Net Margins: -155.20%
• Pretax Margin: -150.95%
• Return on Equity: -28.80%
• Return on Assets: -9.61%

Debt

• Debt-to-Equity Ratio: 2.00
• Current Ratio: 2.76
• Quick Ratio: 2.76

Sales & Book Value

• Annual Sales: $995.55 million
• Price / Sales: 2.67
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $8.04 per share
• Price / Book: 0.55

Miscellaneous

• Outstanding Shares: 601,100,000
• Free Float: 593,526,000
• Market Cap: $2.66 billion
• Optionable: Optionable
• Beta: 1.28